
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
miR-3587 Inhibitor Attenuates Ferroptosis Following Renal Ischemia-Reperfusion Through HO-1
Wenqiang Tao, Fen Liu, Jianguo Zhang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 33
Wenqiang Tao, Fen Liu, Jianguo Zhang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
Heme Oxygenase-1: An Anti-Inflammatory Effector in Cardiovascular, Lung, and Related Metabolic Disorders
Stefan W. Ryter
Antioxidants (2022) Vol. 11, Iss. 3, pp. 555-555
Open Access | Times Cited: 145
Stefan W. Ryter
Antioxidants (2022) Vol. 11, Iss. 3, pp. 555-555
Open Access | Times Cited: 145
Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases
Yumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 71
Yumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 71
The mechanism of ferroptosis and its related diseases
Shijian Feng, Dan Tang, Yichang Wang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 57
Shijian Feng, Dan Tang, Yichang Wang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 57
Ferroptosis inhibitors: past, present and future
Lei Zhang, Yi Luo, Yang Xiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 16
Lei Zhang, Yi Luo, Yang Xiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 16
Ferroptosis and Its Role in Chronic Diseases
Wenli Hu, Kehong Liang, Hong Zhu, et al.
Cells (2022) Vol. 11, Iss. 13, pp. 2040-2040
Open Access | Times Cited: 62
Wenli Hu, Kehong Liang, Hong Zhu, et al.
Cells (2022) Vol. 11, Iss. 13, pp. 2040-2040
Open Access | Times Cited: 62
Targeting Ferroptosis as a Promising Therapeutic Strategy for Ischemia-Reperfusion Injury
Yihang Pan, Xueke Wang, Xiwang Liu, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2196-2196
Open Access | Times Cited: 59
Yihang Pan, Xueke Wang, Xiwang Liu, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2196-2196
Open Access | Times Cited: 59
The molecular mechanisms and potential drug targets of ferroptosis in myocardial ischemia–reperfusion injury
Chen-Hua Zhang, Yujie Yan, Qi Luo
Life Sciences (2024) Vol. 340, pp. 122439-122439
Open Access | Times Cited: 12
Chen-Hua Zhang, Yujie Yan, Qi Luo
Life Sciences (2024) Vol. 340, pp. 122439-122439
Open Access | Times Cited: 12
The emerging role of regulated cell death in ischemia and reperfusion-induced acute kidney injury: current evidence and future perspectives
Chenning Li, Ying Yu, Shuainan Zhu, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Chenning Li, Ying Yu, Shuainan Zhu, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Ferroptosis—A New Dawn in the Treatment of Organ Ischemia–Reperfusion Injury
Linxiang Zhou, Shangting Han, Jiayu Guo, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3653-3653
Open Access | Times Cited: 29
Linxiang Zhou, Shangting Han, Jiayu Guo, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3653-3653
Open Access | Times Cited: 29
Corilagin attenuates intestinal ischemia/reperfusion injury in mice by inhibiting ferritinophagy-mediated ferroptosis through disrupting NCOA4-ferritin interaction
Yunxiang Wang, Bin Li, Guan‐Ting Liu, et al.
Life Sciences (2023) Vol. 334, pp. 122176-122176
Closed Access | Times Cited: 17
Yunxiang Wang, Bin Li, Guan‐Ting Liu, et al.
Life Sciences (2023) Vol. 334, pp. 122176-122176
Closed Access | Times Cited: 17
Biological characteristics of tissue engineered-nerve grafts enhancing peripheral nerve regeneration
Xiangling Li, Hang Xu, Chaochao Li, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Xiangling Li, Hang Xu, Chaochao Li, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
The interplay of miRNAs and ferroptosis in diseases related to iron overload
Shikai Jin, Po‐Tsun Liu, Daheng Zheng, et al.
APOPTOSIS (2023) Vol. 29, Iss. 1-2, pp. 45-65
Closed Access | Times Cited: 15
Shikai Jin, Po‐Tsun Liu, Daheng Zheng, et al.
APOPTOSIS (2023) Vol. 29, Iss. 1-2, pp. 45-65
Closed Access | Times Cited: 15
Advances in Ferroptosis Research: A Comprehensive Review of Mechanism Exploration, Drug Development, and Disease Treatment
Haojie Wang, Yuanyuan Xie
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 334-334
Open Access
Haojie Wang, Yuanyuan Xie
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 334-334
Open Access
Relationship Between ACSL4-Mediated Ferroptosis and Chronic Obstructive Pulmonary Disease
Yingxi Wang, Shuyue Xia
International Journal of COPD (2023) Vol. Volume 18, pp. 99-111
Open Access | Times Cited: 12
Yingxi Wang, Shuyue Xia
International Journal of COPD (2023) Vol. Volume 18, pp. 99-111
Open Access | Times Cited: 12
Ferroptosis: A new mechanism of traditional Chinese medicine compounds for treating acute kidney injury
Yue Shi, Xiujie Shi, Mingming Zhao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114849-114849
Open Access | Times Cited: 12
Yue Shi, Xiujie Shi, Mingming Zhao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114849-114849
Open Access | Times Cited: 12
MTHFR inhibits TRC8‐mediated HMOX1 ubiquitination and regulates ferroptosis in ovarian cancer
Xiang Wang, Zhijie Xu, Xinxin Ren, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 9
Open Access | Times Cited: 17
Xiang Wang, Zhijie Xu, Xinxin Ren, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 9
Open Access | Times Cited: 17
Novel pathways of fluoride-induced hepatotoxicity: P53-dependent ferroptosis induced by the SIRT1/FOXOs pathway and Nrf2/HO-1 pathway
Dongxu Wang, Kai Yin, Yue Zhang, et al.
Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (2022) Vol. 264, pp. 109526-109526
Closed Access | Times Cited: 16
Dongxu Wang, Kai Yin, Yue Zhang, et al.
Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (2022) Vol. 264, pp. 109526-109526
Closed Access | Times Cited: 16
Hyperforin Enhances Heme Oxygenase-1 Expression Triggering Lipid Peroxidation in BRAF-Mutated Melanoma Cells and Hampers the Expression of Pro-Metastatic Markers
Alessia Cardile, Carlotta Passarini, Valentina Zanrè, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1369-1369
Open Access | Times Cited: 9
Alessia Cardile, Carlotta Passarini, Valentina Zanrè, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1369-1369
Open Access | Times Cited: 9
LncRNA HMOX1 alleviates renal ischemia-reperfusion-induced ferroptotic injury via the miR-3587/HMOX1 axis
Wenqiang Tao, Yuanhua Lu, Rui Xiao, et al.
Cellular Signalling (2024) Vol. 119, pp. 111165-111165
Closed Access | Times Cited: 2
Wenqiang Tao, Yuanhua Lu, Rui Xiao, et al.
Cellular Signalling (2024) Vol. 119, pp. 111165-111165
Closed Access | Times Cited: 2
DNA-binding protein-A promotes kidney ischemia/reperfusion injury and participates in mitochondrial function
Charlotte Reichardt, Sabine Brandt, Anja Bernhardt, et al.
Kidney International (2024) Vol. 106, Iss. 2, pp. 241-257
Open Access | Times Cited: 2
Charlotte Reichardt, Sabine Brandt, Anja Bernhardt, et al.
Kidney International (2024) Vol. 106, Iss. 2, pp. 241-257
Open Access | Times Cited: 2
The role of microRNAs in ferroptosis
Liqing Guo, Qingkun Zhang, Yuehui Liu
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 12
Liqing Guo, Qingkun Zhang, Yuehui Liu
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 12
Xanthohumol attenuates renal ischemia/reperfusion injury by inhibiting ferroptosis
Zhe Tang, Ye Feng, Wen Nie, et al.
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 6
Open Access | Times Cited: 6
Zhe Tang, Ye Feng, Wen Nie, et al.
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 6
Open Access | Times Cited: 6
The significance of ferroptosis in renal diseases and its therapeutic potential
Mingzhu Jiang, Shujun Wu, Kun Xie, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35882-e35882
Closed Access | Times Cited: 1
Mingzhu Jiang, Shujun Wu, Kun Xie, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35882-e35882
Closed Access | Times Cited: 1
Ginsenoside Rb1 targets to HO-1 to improve sepsis by inhibiting ferroptosis
Shasha He, Haoran Ye, Qian Wang, et al.
Free Radical Biology and Medicine (2024) Vol. 226, pp. 13-28
Closed Access | Times Cited: 1
Shasha He, Haoran Ye, Qian Wang, et al.
Free Radical Biology and Medicine (2024) Vol. 226, pp. 13-28
Closed Access | Times Cited: 1
Identification of RPS7 as the Biomarker of Ferroptosis in Acute Kidney Injury
Hao Zhang, Xuemei Liu, Lizhi Zhou, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 7
Hao Zhang, Xuemei Liu, Lizhi Zhou, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 7